2011
DOI: 10.1016/j.anai.2010.08.009
|View full text |Cite
|
Sign up to set email alerts
|

Potential therapies for peanut allergy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 57 publications
(51 reference statements)
0
1
0
Order By: Relevance
“…7 These are associated with high rates of adverse reactions or low efficacy. 8 Compared with crude peanut extract (CPE), 9 peptide-based immunotherapy using T cell epitope-containing peptides (too short to effectively cross-link allergen-specific IgE on mast cells and basophils) might provide efficacious desensitization without significant reactions. This has been achieved in allergic subjects with Fel d 1 for cat allergy, 10 phospholipase A 2 for vespid allergy 11 and with ovalbumin (egg) 12 and Ara h 1 in mice with egg and peanut allergy.…”
mentioning
confidence: 99%
“…7 These are associated with high rates of adverse reactions or low efficacy. 8 Compared with crude peanut extract (CPE), 9 peptide-based immunotherapy using T cell epitope-containing peptides (too short to effectively cross-link allergen-specific IgE on mast cells and basophils) might provide efficacious desensitization without significant reactions. This has been achieved in allergic subjects with Fel d 1 for cat allergy, 10 phospholipase A 2 for vespid allergy 11 and with ovalbumin (egg) 12 and Ara h 1 in mice with egg and peanut allergy.…”
mentioning
confidence: 99%